Immune Repertoire and Advancements in Nanotherapeutics for the Impediment of Severe Steroid Resistant Asthma (SSR)

Severe steroid-resistant asthma (SSR) patients do not respond to the corticosteroid therapies due to the heterogeneity, and genome-wide variations. However, there are very limited reports pertinent to the molecular signaling underlying SSR and making pharmacologists, and formulation scientists to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Beeraka, Narasimha M, Zhou, Runze, Wang, Xiaoyan, Vikram P R, Hemanth, Kumar, Tegginamath Pramod, Liu, Junqi, Greeshma, M V, Mandal, Subhankar P, Gurupadayya, B M, Fan, Ruitai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112344/
https://www.ncbi.nlm.nih.gov/pubmed/35592101
http://dx.doi.org/10.2147/IJN.S364693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112344/
https://www.ncbi.nlm.nih.gov/pubmed/35592101
http://dx.doi.org/10.2147/IJN.S364693

Ejemplares similares